+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

A novel superoxide dismutase mimetic causes rodent tumor regression and vascular destabilization



A novel superoxide dismutase mimetic causes rodent tumor regression and vascular destabilization



Proceedings of the American Association for Cancer Research Annual Meeting 44: 604-605




(PDF emailed within 1 workday: $29.90)

Accession: 034312338

Download citation: RISBibTeXText


Related references

Protective effects of M40403, a superoxide dismutase mimetic, in a rodent model of colitis. European Journal of Pharmacology 432(1): 79-89, 30 November, 2001

Protective effects of a newly developed superoxide dismutase mimetic on ischemia reperfusion injury in rodent cardiac allografts. Circulation 104(17 Supplement): II 555, October 23, 2001

Attenuation of the lethal phenotype of mice lacking Mn superoxide dismutase by treatment with a superoxide dismutase mimetic. American Journal of Human Genetics 59(4 SUPPL ): A208, 1996

Superoxide dismutase mimetic m40401 reduces ischemia-reperfusion injury and graft coronary artery disease in rodent cardiac allografts. Transplantation 78(8): 1166-1171, 2004

The neuroprotective properties of the superoxide dismutase mimetic tempol correlate with its ability to reduce pathological glutamate release in a rodent model of stroke. Free Radical Biology and Medicine 77: 168-182, 2015

Sequencing effects of a superoxide dismutase mimetic on tumor radioresponsiveness. International Journal of Radiation Oncology Biology Physics 57(2 Supplement): S159, 2003

A manganese porphyrin superoxide dismutase mimetic enhances tumor radioresponsiveness. International Journal of Radiation Oncology, Biology, Physics 63(2): 545-552, 2005

Superoxide dismutase mimetic, tempol reduces arterial pressure and renal vascular resistance in salt restricted dogs. FASEB Journal 16(4): A432, March 20, 2002

Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats. Journal of Hepatology 54(4): 660-665, 2011

Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 32(1): 59-64, 1998

Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. American Journal of Hypertension 15(1 Part 1): 78-84, 2002

Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: role of mitochondrial superoxide. Free Radical Biology and Medicine 39(5): 567-583, 2005

Phthalic acid mono n butyl ester cupric salt a superoxide dismutase mimetic agent inhibits tpa caused tumor promotion but not tumor promotion caused by 7 bromomethylbenz a anthracene. Journal of Cancer Research & Clinical Oncology 116(SUPPL PART 1): 99, 1990

Superoxide dismutase mimetic, MnTE-2-PyP, attenuates chronic hypoxia-induced pulmonary hypertension, pulmonary vascular remodeling, and activation of the NALP3 inflammasome. Antioxidants and Redox Signaling 18(14): 1753-1764, 2013